Faculty Bibliography

PURPOSE: To determine if pretreatment apparent diffusion coefficient (ADC) of leiomyomas could predict volumetric response (VR) following uterine artery embolization (UAE). MATERIALS AND METHODS: We retrospectively studied 11 women who underwent pelvic MRI before and >120 days following UAE. MRI included conventional and diffusion weighted imaging sequences. Percentage change in leiomyoma volume was determined by multiplanar T2-weighted imaging. A Pearson correlation coefficient was calculated between leiomyoma VR following UAE and the following pre-embolization parameters: initial volume, relative enhancement, relative T2 signal intensity (SI) and ADC. Receiver operating characteristic (ROC) curve analysis was used to determine the sensitivity and specificity of ADC for predicting volumetric response. RESULTS: Twenty-eight leiomyomas were included with a mean interval from UAE to follow-up MRI of 207 days. The preprocedural volume of the leiomyomas ranged from 18 to 182 cm(3) (median 47 cm(3)). and ADC ranged from 0.37 to 1.71 mm(2)/s (mean 0.80 mm(2)/s). All leiomyomas were 100% necrotic following UAE. Leiomyoma VR following UAE was 48% +/- 3.5%. with significant correlation between VR and ADC (r = 0.41; P = 0.017) but no correlation with initial leiomyoma volume, relative T2 SI, or relative enhancement. Using a threshold of 0.875 x 10(-3) mm(2)/s, ADC could predict > 50% VR with sensitivity and specificity of 70% and 83%, respectively. CONCLUSION: Pre-UAE ADC of leiomyomas correlated significantly with percent VR following UAE. In contrast, no correlation was seen between VR post-UAE and conventional imaging findings. This suggests that VR following UAE depends on leiomyoma histology reflected in DWI rather than features revealed by conventional MRI

Renal masses increasingly are detected incidentally in asymptomatic individuals. Accurate characterization of these lesions is important for clinical management, planning intervention, and avoiding unnecessary procedures. Ultrasonography, computed tomography (CT), and magnetic resonance imaging (MRI) are the mainstays of renal mass detection and characterization. Ultrasonography is useful for distinguishing cystic from solid lesions and can detect lesion vascularity, especially with use of ultrasound contrast agents, but is less sensitive, less specific, and less reproducible than CT and MRI. CT, with and without intravenous contrast, is the primary imaging test for characterization and staging of renal lesions, and is utilized more often than MRI. Current multidetector CT technology provides near isotropic acquisition, with three-dimensional reformatting capabilities. Due to lack of exposure to iodinated contrast and ionizing radiation and superior soft tissue contrast, MRI is being increasingly utilized as a problem-solving tool for diagnosis, staging, and preoperative planning for renal malignancies. Future directions for imaging of primary renal neoplasm include accurate characterization of renal cell cancer subtype, assistance with treatment planning, and evaluation of treatment response

OBJECTIVE: The purpose of our study is to present the radiographic findings in a series of 16 patients with complications associated with intravesical bacille Calmette-Guerin (BCG) treatment of bladder cancer. CONCLUSION: Intravesical BCG-related complications such as granulomatous disease may show imaging findings mimicking primary or metastatic tumors in patients with bladder cancer. Radiologists should consider this possibility when imaging abnormalities are encountered in bladder cancer patients treated with intravesical BCG so that appropriate management can be administered and unnecessary procedures avoided

PURPOSE: To retrospectively determine the distribution of growth rates across different sizes and subtypes of renal cortical tumors by assessing tumor volume and maximum tumor diameter at serial volumetric computed tomographic (CT) examinations. MATERIALS AND METHODS: The institutional review board approved this retrospective, HIPAA-compliant study. Fifty-three of 2304 patients (34 men, 19 women; mean age, 67 years +/- 10 [standard deviation; range, 39-88 years) who underwent nephrectomy from 1989 to 2006 did not receive preoperative chemotherapy or radiation therapy and underwent at least two preoperative contrast material-enhanced CT examinations (at least 3 months apart) with identical section thickness that was no more than one-fifth of longitudinal tumor diameter. Tumor volume and maximum diameter were measured on CT scans. Reciprocal of doubling time (DT) (RDT) was calculated. Analysis of variance and Student t tests were performed. RESULTS: Thirty-two clear cell carcinomas, 10 papillary carcinomas, six chromophobe carcinomas, four oncocytomas, and one angiomyolipoma were analyzed. Median tumor size was 2.9 cm (range, 1-12 cm). Seven tumors did not increase in volume. DT ranged from -248 to 72 days (mean, 474 days; median, 811 days). Growth rate determined by using maximum diameter ranged from -10.8 to 33.2 mm/y (mean, 5.1 mm/y; median, 3.5 mm/y). Faster-growing tumors were more likely to be clear cell carcinomas, those of higher grade had higher growth rates. No significant correlation was found between RDT and tumor initial volume, subtype, or grade. Small renal tumors (<or=3.5 cm) were similar to larger tumors in subtype and growth rate. Age at diagnosis correlated negatively with renal tumor growth rate (P = .03). CONCLUSION: Growth rates in renal tumors of different sizes, subtypes, and grades represent a wide range and overlap substantially. Small renal tumors appear to be similar to larger ones in nature